Concepedia
Statistics
Publications
21
Citations
1.6K
H-Index
19
Active since
2007
Affiliations
Inserm(Current)
Université Claude Bernard Lyon 1
Centre de Recherche en Cancérologie de Lyon
Centre Léon Bérard
Lebanese University
Sandra E. Ghayad is an author at Inserm specializing in medicine, molecular oncology, and oncology.
Publications per year
2007–2023
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer
Virginie Marcel, Sandra E. Ghayad, Stéphane Belin et al. · Cancer Cell · 2013 · 354 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +16
Evidence for rRNA 2′-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes
Jenny Erales, Virginie Marchand, Baptiste Panthu et al. · Proceedings of the National Academy of Sciences · 2017 · 291 citations
Life Sciences, Biochemistry, Molecular Biology +15
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
Sandra E. Ghayad, Julie A. Vendrell, Sabrina Ben Larbi et al. · International Journal of Cancer · 2009 · 131 citations
Medicine, Oncology, Pharmacology +17
ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion
Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen et al. · Cancer Research · 2012 · 131 citations · Full text
Medicine, Cell Biology, Oncology +17
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
Julie A. Vendrell, Sandra E. Ghayad, S Ben-Larbi et al. · Oncogene · 2007 · 92 citations
Medicine, Genetics, Oncology +14
1–5 of 21